Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice ...

Sanofi is in talks with CD&R to sell a 50% stake in its consumer healthcare unit, Opella. PAI Partners raised its bid by 200 ...

Sanofi is reorganising its business units from seven to five in ... executive vice president of global commercial operations. Sanofi Pasteur and Merial will continue as Sanofi's vaccines and ...

PAI Partners has submitted an improved offer for Sanofi’s consumer health business, according to people familiar with the ...

Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare ...

PARIS (Reuters) -French unions have called on workers at Sanofi to strike from Thursday to protest a planned sale of the ...

Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella. Sanofi said any further updates on the ...

On Friday, Sanofi said it’s in negotiations with the private equity firm Clayton Dubilier & Rice for the potential sale of a 50% controlling stake in the consumer business, named Opella.

Sanofi (SNYNF) Company Description: Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals ...

PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical ...

Sanofi said last week it had entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, a year after flagging ...